Abstract
Purpose. The pharmacokinetics of plasmid DNA after IV bolus administration in the rat by following supercoiled (SC), open circular (OC), and linear (L) pDNA forms of the plasmid.
Methods. SC, OC, and L pDNA were injected at 2500, 500, 333, and 250 μg doses. The concentrations in the bloodstream of OC and L pDNA were monitored.
Results. SC pDNA was detectable in the bloodstream only after a 2500 μg dose, and had a clearance of 390(±50) ml/min and Vd of 81(±8) ml. The pharmacokinetics of OC pDNA exhibited non-linear characteristics with clearance ranging from 8.3(±0.8) to 1.3(±0.2) ml/min and a Vd of 39(±19) ml. L pDNA was cleared at 7.6(±2.3) ml/min and had a Vd of 37(±17) ml. AUC analysis revealed that 60(±10) % of the SC was converted to the OC form, and nearly complete conversion of the OC pDNA to L pDNA. Clearance of SC pDNA was decreased after liposome complexation to 87(±30) ml/min. However the clearance of OC and L pDNA was increased relative to naked pDNA at an equivalent dose to 37(±9) ml/min and 95(±37) ml/min respectively.
Conclusions. SC pDNA is rapidly metabolized and cleared from the circulation. OC pDNA displays non-linear pharmacokinetics. Linear pDNA exhibits first order kinetics. Liposome complexation protects the SC topoform, but the complexes are more rapidly cleared than the naked pDNA.
Similar content being viewed by others
REFERENCES
A. Noll, N. Bucheler, E. Bohn, R. Schirmbeck, J. Reimann, and I. B. Autenrieth. DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria. Eur. J. Immunol. 29:986-996 (1999).
J. Haensler, C. Verdelet, V. Sanchez, Y. Girerd-Chambaz, A. Bonnin, E. Trannoy, S. Krishnan, and P. Meulien. Intradermal DNA immunization by using jet-injectors in mice and monkeys. Vaccine 17:628-638 (1999).
J. E. Osorio, C. C. Tomlinson, R. S. Frank, E. J. Haanes, K. Rushlow, J. R. Haynes, and D.T. Stinchcomb. Immunization of dogs and cats with a DNA vaccine against rabies virus. Vaccine 17:1109-1116 (1999).
G. Rizzuto, M. Cappelletti, D. Maione, R. Savino, D. Lazzaro, P. Costa, I. Mathiesen, R. Cortese, G. Ciliberto, R. Laufer, N. La Monica, and E. Fattori. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc. Natl. Acad. Sci. U S A 96:6417-6422 (1999).
V. Budker, G. Zhang, I. Danko, P. Williams, and J. Wolff. The efficient expression of intravascularly delivered DNA in rat muscle. Gene Therapy 5:272-276 (1998).
Y. K. Song, F. Liu, and D. Liu. Enhanced gene expression in mouse lung by prolonging the retention time of intravenously injected plasmid DNA. Gene Therapy 5:1531-1537 (1998).
C. Wang, L. Chao, and J. Chao. Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats [see comments]. J. Clin. Invest. 95:1710-1716 (1995).
G. Zhang, V. Budker, and J. A. Wolff. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Human Gene Therapy 10:1735-1737 (1999).
F. Liu, Y. K. Song, and D. Liu. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Therapy 6:1-9 (1999).
G. Osaka, K. Carey, A. Cuthbertson, P. Godowski, T. Patapoff, A. Ryan, T. Gadek, and J. Mordenti. Pharmacokinetics, tissue distribution, and expression efficiency of plasmid [33P] DNA following intravenous administration of DNA/cationic lipid complexes in mice: Use of a novel radionucleolide approach. J. Pharm. Sci. 85:612-618 (1996).
A. R. Thierry, R. Rabinovich, B. Peng, L. C. Mahan, J. L. Bryant, and R. C. Gallo. Characterization of liposome-mediated gene delivery: Expression, stability, and pharmacokinetics of plasmid DNA. Gene Therapy 4:226-237 (1997).
D. Lew, S. E. Parker, T. Latimer, A. M. Abai, A. Kuwahara-Rundell, S. G. Doh, Z.-Y. Yang, D. Laface, S. H. Gromkowski, G. J. Nabel, M. Manthorpe, and J. Norman. Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice. Human Gene Therapy 6:553-564 (1995).
L. Katz, P. H. Williams, S. Sato, R. W. Leavitt, and R. H. Donald. Purification and characterization of covalently closed replicative intermediates of ColE1 DNA from Escherichia coli. Biochemistry 16:1677-1683 (1977).
B. E. Houk, G. Hochhaus, and J. A. Hughes, Kinetic modeling of plasmid DNA degradation in rat plasma. Pharm. Sci. 1: (1999).
C. R. Cantor and P. R. Schimmel. Biophysical Chemistry Part III: The Behavior Of Biological Macromolecules, W.H. Freeman and Company, New York, 1980.
D. R. Smith and D. Murphy (eds.). Capillary blotting of agarose gels. Methods in Molecular Biology, Vol. 58, Humana Press Inc., Totowa, NJ, 1991 pp. 23-25.
M. Gibaldi and D. Perrier. Pharmacokinetics, 2nd ed., Marcel Dekker Inc., New York, 1982.
S. Chitrabamrung, J. S. Bannett, R. L. Rubin, and E. M. Tan. A radial diffusion assay for plasma and serum deoxyribonuclease I. Rheumatol. Int. 1:49-53 (1981).
C. H. Gosse, J. B. Le Pecq, P. Defrance, and C. Padetti. Initial degradation of deoxyribonucleic acid after injection in mammals. Cancer Res. 25:877 (1965).
T. M. Chused, A. D. Steinberg, and N. Talal. The clearance and localization of nucleic acids by New Zealand and normal mice. Clin. and Exp. Immunol. 12:465-476 (1972).
M. A. Dwyer, A. J. Huang, C. Q. Pan, and R. A. Lazarus. Expression and characterization of a DNase I-Fc fusion enzyme. J. Biol. Chem. 274:9738-9743 (1999).
H. Takeshita, T. Yasuda, T. Nakajima, O. Hosomi, Y. Nakashima, and K. Kishi. Mouse deoxyribonuclease I (DNase I): Biochemical and immunological characterization, cDNA structure, and tissue distribution. Biochem. Mol. Biol. Int. 42:65-75 (1997).
R. I. Mahato, K. Kawabata, T. Nomura, Y. Takakura, and M. Hashida. Physiochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes. J. Pharm. Sci. 84:1267-1271 (1995).
F. Poly, C. Chenu, P. Simonet, J. Rouiller, and L. J. Monrozier. Differences between linear chromasomal and supercoiled plasmid DNA in their mechanisms and extent of adsorption on clay minerals. Langmuir 15:5-8 (1999).
K. A. Melzak, C. S. Sherwood, R. F. B. Turner, and C. A. Haynes. Driving forces for DNA adsorption to silica in percholate solutions. J. Colloid Int. Sci. 181:635-644 (1996).
H. Lodish, D. Baltimore, A. Berk, S. Z. Lawrence, P. Matsudaira, and J. Darnell. Molecular Cell Biology, 3rd ed., Scientific American Books, New York, 1995.
R. L. Juliano. Factors affecting the clearance kinetics and tissue distribution of liposomes, microspheres and emulsions. Adv. Drug Del. Rev. 2:31-54 (1988).
E. G. Yarmola, M. I. Zarudnaya, and Y. S. Lazurkin. Osmotic pressure of DNA solutions and effective diameter of the double helix. J. Biomol. Struct. Dyn. 2:981-993 (1985).
M. Yoshida, R. I. Mahato, K. Kawabata, Y. Takakura, and M. Hashida. Disposition characteristics of plasmid DNA in the single-pass rat liver perfusion system. Pharm. Res. 13:599-603 (1996).
R. Niven, R. Pearlman, T. Wedking, J. Mackeigan, P. Noker, L. Simpson-Herren, and J. G. Smith. Biodistribution of radiolabeled lipid-DNA complexes and DNA in mice. J. Pharm. Sci. 87:1292-1299 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Houk, B.E., Martin, R., Hochhaus, G. et al. Pharmacokinetics of Plasmid DNA in the Rat. Pharm Res 18, 67–74 (2001). https://doi.org/10.1023/A:1011078711008
Issue Date:
DOI: https://doi.org/10.1023/A:1011078711008